ArticleOncoTargets and therapy2018

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma.

Jie Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.